X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | IVF | Invo Fertility, Inc. | Szot Matthew K | Dir | S - Sale+OE | $1.52 | -4 | 0 | -100% | -$6 | |||||
| M | 2025-12-03 | ALUR | Allurion Technologies, Inc. | Davin Michael R | Dir | S - Sale | $1.53 | -3,212 | 1,206 | -73% | -$4,918 | |||||
2025-12-04 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.85 | +10,130 | 828,040 | +1% | +$18,741 | ||||||
| D | 2025-12-03 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $45.46 | -30,921 | 800,993 | -4% | -$1,405,700 | |||||
2025-12-03 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $45.30 | -7,315 | 156,093 | -4% | -$331,370 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $29.34 | -1,063 | 90,752 | -1% | -$31,184 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $29.34 | -1,427 | 42,614 | -3% | -$41,862 | ||||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $29.34 | -3,278 | 97,924 | -3% | -$96,163 | ||||||
2025-12-02 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $139.00 | -1,200 | 27,846 | -4% | -$166,800 | ||||||
2025-12-03 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $251.47 | -2,000 | 68,773 | -3% | -$502,940 | ||||||
| D | 2025-12-01 | GMED | Globus Medical Inc | Kline Kyle | SVP, CFO | S - Sale+OE | $90.00 | -18,542 | 0 | -100% | -$1,668,780 | |||||
| D | 2025-12-01 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale+OE | $1.57 | -8,805 | 2,220,322 | 0% | -$13,824 | |||||
2025-12-01 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.57 | -6,322 | 373,466 | -2% | -$9,926 | ||||||
2025-12-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $294.94 | -600 | 64,136 | -1% | -$176,966 | ||||||
2025-12-02 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $292.98 | -100 | 8,416 | -1% | -$29,298 | ||||||
2025-12-01 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.57 | -10,278 | 252,992 | -4% | -$16,136 | ||||||
2025-12-01 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $22.11 | -100,000 | 5,524,978 | -2% | -$2,211,000 | ||||||
| D | 2025-12-02 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale+OE | $45.56 | -30,921 | 800,993 | -4% | -$1,408,730 | |||||
2025-11-28 | AURX | Nuo Therapeutics, Inc. | Jorden David Emerson | CEO, CFO | S - Sale | $1.50 | -200,000 | 1,946,755 | -9% | -$300,000 | ||||||
2025-12-02 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | CHIEF COMM, PRODUCT OFFICER | S - Sale | $184.83 | -280 | 43,387 | -1% | -$51,752 | ||||||
2025-12-02 | IRTC | Irhythm Technologies, Inc. | Murphy Patrick Michael | CBO, CLO | S - Sale | $184.83 | -2,478 | 53,281 | -4% | -$458,009 | ||||||
2025-12-02 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $8.25 | -2,518 | 158,845 | -2% | -$20,774 | ||||||
2025-12-01 | BDX | Becton Dickinson & Co | Feld Michael | EVP, CRO, Pres Life Sciences | S - Sale | $193.36 | -75 | 16,580 | 0% | -$14,502 | ||||||
| D | 2025-12-01 | BSX | Boston Scientific Corp | Butcher Arthur C | EVP,Grp Pres, MedSurg, APAC | S - Sale+OE | $101.55 | -17,313 | 36,954 | -32% | -$1,758,189 | |||||
2025-12-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $244.16 | -50 | 9,791 | -1% | -$12,208 | ||||||
2025-12-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $244.16 | -1,000 | 87,495 | -1% | -$244,160 | ||||||
2025-12-01 | BBNX | Beta Bionics, Inc. | Lezack Adam | Dir | S - Sale | $29.55 | -1,406 | 8,435 | -14% | -$41,543 | ||||||
2025-12-01 | BBNX | Beta Bionics, Inc. | Palasis Maria | Dir | S - Sale | $29.55 | -1,406 | 8,435 | -14% | -$41,552 | ||||||
2025-11-28 | OSUR | Orasure Technologies Inc | Gagliano Nancy J | Dir | P - Purchase | $2.37 | +2,100 | 160,254 | +1% | +$4,982 | ||||||
2025-12-01 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $92.76 | -5,000 | 4,527,950 | 0% | -$463,794 | ||||||
2025-11-28 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $127.48 | -2,000 | 29,046 | -6% | -$254,960 | ||||||
2025-11-25 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.70 | +3,000 | 280,575 | +1% | +$5,100 | ||||||
| D | 2025-11-25 | GMED | Globus Medical Inc | Huller Kelly | SVP, GC, Corporate Secretary | S - Sale+OE | $90.00 | -7,500 | 0 | -100% | -$675,000 | |||||
2025-11-25 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $300.06 | -1,800 | 64,736 | -3% | -$540,108 | ||||||
2025-11-25 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $300.19 | -7,500 | 274,020 | -3% | -$2,251,425 | ||||||
| D | 2025-11-25 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale+OE | $8.08 | -44,850 | 256,590 | -15% | -$362,388 | |||||
2025-11-24 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $20.00 | -400 | 251,496 | 0% | -$8,000 | ||||||
2025-11-25 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $105.00 | -315 | 50,488 | -1% | -$33,075 | ||||||
| DM | 2025-11-24 | ATRC | Atricure, Inc. | Wehrwein Sven | Dir | S - Sale+OE | $37.66 | -10,000 | 34,374 | -23% | -$376,578 | |||||
2025-11-26 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $37.29 | -5,166 | 78,798 | -6% | -$192,640 | ||||||
2025-11-24 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.70 | -55,000 | 728,294 | -7% | -$93,500 | ||||||
| D | 2025-11-25 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Exec COB | S - Sale+OE | $88.04 | -10,000 | 1,126,457 | -1% | -$880,377 | |||||
2025-11-25 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $255.00 | -2,055 | 4,261 | -33% | -$524,025 | ||||||
2025-11-24 | ATEC | Alphatec Holdings, Inc. | Pritzker Jennifer N. | 10% | S - Sale | $20.62 | -250,000 | 13,715,781 | -2% | -$5,155,000 | ||||||
2025-11-24 | ATEC | Alphatec Holdings, Inc. | Squadron Capital Holdings LLC | 10% | S - Sale | $20.62 | -250,000 | 10,895,045 | -2% | -$5,155,000 | ||||||
2025-11-21 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $290.56 | -7,500 | 283,319 | -3% | -$2,179,212 | ||||||
2025-11-24 | ATEC | Alphatec Holdings, Inc. | Pelizzon David R | Dir, 10% | S - Sale | $20.62 | -250,000 | 11,241,872 | -2% | -$5,155,000 | ||||||
2025-11-24 | ATEC | Alphatec Holdings, Inc. | Squadron Capital LLC | 10% | S - Sale | $20.62 | -250,000 | 10,895,045 | -2% | -$5,155,000 | ||||||
| M | 2025-11-21 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $20.01 | -1,300 | 203,773 | -1% | -$26,016 | |||||
2025-11-21 | DCTH | Delcath Systems, Inc. | Sylvester John Richard | Dir | P - Purchase | $8.89 | +4,386 | 14,936 | +42% | +$38,992 | ||||||
2025-11-25 | ICUI | Icu Medical Inc/De | Woolson Daniel | VP, GM-Infusion Capital | S - Sale | $152.35 | -2,897 | 11,297 | -20% | -$441,364 | ||||||
2025-11-21 | ATRC | Atricure, Inc. | Yuen Maggie | Dir | S - Sale | $35.72 | -3,000 | 11,371 | -21% | -$107,160 | ||||||
| M | 2025-03-20 | INSP | Inspire Medical Systems, Inc. | Curet Myriam | Dir | P - Purchase | $160.72 | +5 | 3,365 | 0% | +$804 | |||||
| M | 2025-05-08 | INSP | Inspire Medical Systems, Inc. | Curet Myriam | Dir | S - Sale | $102.59 | -6 | 3,365 | 0% | -$616 | |||||
| D | 2025-11-21 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Exec COB | S - Sale+OE | $87.31 | -25,000 | 1,136,457 | -2% | -$2,182,750 | |||||
| D | 2025-11-21 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $45.04 | -47,376 | 44,753 | -51% | -$2,133,920 | |||||
2025-11-24 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $90.36 | -5,000 | 4,532,950 | 0% | -$451,814 | ||||||
| D | 2025-11-20 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.18 | -15,276 | 44,753 | -25% | -$674,825 | |||||
2025-11-20 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $19.51 | -70,000 | 368,331 | -16% | -$1,365,700 | ||||||
| D | 2025-11-20 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale+OE | $19.80 | -25,000 | 672,207 | -4% | -$495,000 | |||||
2025-11-20 | IRMD | Iradimed Corp | Hawkins James B | Dir | S - Sale | $88.24 | -3,000 | 30,545 | -9% | -$264,717 | ||||||
2025-11-21 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.93 | +7,000 | 140,113 | +5% | +$27,510 | ||||||
| D | 2025-11-20 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Exec COB | S - Sale+OE | $85.13 | -20,000 | 1,161,457 | -2% | -$1,702,650 | |||||
2025-11-18 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale | $90.00 | -19,340 | 92,366 | -17% | -$1,740,600 | ||||||
2025-11-20 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +100,000 | 10,635,090 | +1% | +$6,220 | ||||||
| D | 2025-11-18 | MMSI | Merit Medical Systems Inc | Lampropoulos Fred P. | Exec COB | S - Sale+OE | $84.83 | -5,000 | 1,181,457 | 0% | -$424,130 | |||||
2025-11-20 | SYK | Stryker Corp | Wells Preston Wendell | VP, CFO | S - Sale | $365.88 | -165 | 6,981 | -2% | -$60,370 | ||||||
2025-11-13 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $4.50 | +2,500 | 133,113 | +2% | +$11,250 | ||||||
2025-11-17 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $17.44 | -3,833 | 268,144 | -1% | -$66,832 | ||||||
2025-11-17 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $17.41 | -3,328 | 251,896 | -1% | -$57,934 | ||||||
2025-11-17 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $17.43 | -3,460 | 205,073 | -2% | -$60,297 | ||||||
| M | 2025-11-17 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $17.51 | -16,752 | 759,682 | -2% | -$293,385 | |||||
2025-11-19 | ARAY | Accuray Inc | La Neve Stephen R. | CEO | P - Purchase | $0.97 | +20,000 | 20,000 | New | +$19,410 | ||||||
2025-11-18 | AORT | Artivion, Inc. | Hoff Elizabeth A | Dir | S - Sale | $45.10 | -4,200 | 27,189 | -13% | -$189,412 | ||||||
2025-11-18 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $85.59 | -5,000 | 4,537,950 | 0% | -$427,957 | ||||||
2025-11-18 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | P - Purchase | $4.03 | +25,000 | 1,200,293 | +2% | +$100,750 | ||||||
2025-11-18 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $3.80 | +1,000 | 118,839 | +1% | +$3,800 | ||||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Foster Steven M | CEO, Pres | P - Purchase | $0.00 | +19,455 | 22,878 | +568% | +$0 | |||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Geist Wyatt D. | Chief Innovation Officer | P - Purchase | $0.00 | +19,455 | 508,334 | +4% | +$0 | |||||
| D | 2025-11-14 | TNON | Tenon Medical, Inc. | Grawey Nathaniel A. | Chief Commercial Officer | P - Purchase | $0.00 | +101,167 | 414,664 | +32% | +$0 | |||||
2025-11-17 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $7.06 | -14,418 | 170,831 | -8% | -$101,791 | ||||||
2025-11-17 | SSKN | Strata Skin Sciences, Inc. | Rubinstein Samuel | Dir | S - Sale | $1.33 | -14,094 | 8,766 | -62% | -$18,804 | ||||||
2025-11-18 | SSKN | Strata Skin Sciences, Inc. | Rubinstein Samuel | Dir | P - Purchase | $1.41 | +5,000 | 8,766 | +133% | +$7,028 | ||||||
| A | 2025-11-11 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $4.27 | +2,000 | 118,839 | +2% | +$8,546 | |||||
| DM | 2025-11-14 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $45.09 | -12,787 | 163,408 | -7% | -$576,502 | |||||
| DM | 2025-11-14 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale+OE | $44.92 | -12,787 | 198,842 | -6% | -$574,392 | |||||
2025-11-17 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $45.73 | -6,000 | 135,380 | -4% | -$274,380 | ||||||
2025-11-14 | DXCM | Dexcom Inc | Collins Richard Alexander | Dir | S - Sale | $59.05 | -2,906 | 40,162 | -7% | -$171,599 | ||||||
2025-11-14 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.07 | +5,000 | 1,064,727 | 0% | +$20,350 | ||||||
2025-11-17 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See Remarks, 10% | P - Purchase | $1.11 | +3,604,000 | 7,714,709 | +88% | +$4,000,440 | ||||||
| D | 2025-11-14 | SYK | Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | S - Sale+OE | $365.49 | -1,953 | 3,446 | -36% | -$713,802 | |||||
2025-11-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.77 | +5,731 | 16,662,822 | 0% | +$4,424 | ||||||
| D | 2025-11-12 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale+OE | $8.01 | -3,150 | 256,590 | -1% | -$25,232 | |||||
| D | 2025-11-13 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.82 | -13,629 | 6,460 | -68% | -$2,314,538 | |||||
| D | 2025-11-13 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.78 | -13,826 | 6,460 | -68% | -$2,347,371 | |||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Squadron Capital Holdings LLC | 10% | S - Sale | $20.80 | -250,000 | 11,145,045 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Pritzker Jennifer N. | 10% | S - Sale | $20.80 | -250,000 | 13,965,781 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Pelizzon David R | Dir, 10% | S - Sale | $20.80 | -250,000 | 11,491,872 | -2% | -$5,200,000 | ||||||
2025-11-12 | ATEC | Alphatec Holdings, Inc. | Squadron Capital LLC | 10% | S - Sale | $20.80 | -250,000 | 11,145,045 | -2% | -$5,200,000 | ||||||
2025-11-13 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $45.86 | -3,482 | 141,380 | -2% | -$159,678 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |